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Materials/Methods: 1 participant ran on a treadmill that was 
accelerating between speeds of 0 and 18 Km/h in 2 minutes. 
CODA automated motion analysis system was used to collect 
3D kinematic data from 14 markers placed on the head, 
shoulders, elbows, wrists, hips, knees, ankles of the 
participant (sampling frequency 100 Hz, trial length 120 s). 
Marker position and acceleration data were analysed in the x, 
y and z directions. 
Individual and combined sensor measurements were 
resampled at 4000Hz to generate audible waveforms. 
Sonograms were then computed using moving Hanning 
windows for all the sound signals computed for each marker 
and combination of markers. 
Results: Sonification of individual and combined markers are 
shown in Figure 1. The transition between the walking and 
running gaits is clearly visible in all of the sonograms (Figure 
1). Sonification of individual markers (Figure 1, top left) 
shows the frequencies underpinning the marker movement. 
Combining the markers, sonification shows the cancellation 
and enhancement of frequencies involved in the gait as a 
result of coupling the marker waveforms (Figure 1, top right 
and bottom). 
 
 
Figure 1: Sonograms of vertical components of: Top left – 
left knee marker; Top right – Left leg = left knee, ankle and 
hip markers; Bottom left – Left leg combined with Right arm 
= right wrist, elbow and shoulder markers; Bottom right – 
Whole body = combined left leg, right leg, left arm, right 
arm and head markers 
 
Conclusion: Sonification provides a measure that clearly 
shows the phase transition between walking and running 
gaits. Furthermore, this measure is individual specific and 
situation specific. It is proposed that this method could be a 
used as a key tool for understanding and identifying and 
tracking changes in pathological or perturbed gaits; informing 
health practice.  
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Purpose: Cathepsin L (CTSL) has been shown to play a role in 
tumour development and progression through its proteolytic 
activities. An increased expression and secretion of CTSL 
from cancerous cells enhances the tumour cell migration, 
aids in tumour invasion and promotes angiogenesis. In the 
present study we have investigated the role of the small 
molecule cathepsin L inhibitor, KGP94, on tumour initiation 
and metastatic spread in murine tumour models.  
Methods: The C3H mammary carcinoma was implanted 
subcutaneously into the foot of male CDF1 mice. The SCCVII 
squamous cell carcinoma was either implanted into the foot 
or intravenously injected into the tail vein of C3H/HeNHsd 
mice. KGP94 was prepared by dissolving in a mixture of 10% 
Tween 80 and 90% HEPES-buffer. It was intraperitoneally 
(i.p.) injected at 0.01ml/g mouse bodyweight. Various doses 
(1-20mg/kg) were administered starting from the day of 
tumour implantation/injection. Tumour response was 
assessed by either determining the tumour growth time for 
foot tumours or the number of lung metastasis for the 
injections. Tumour growth time was assessed using a caliper 
and was the time in days to reach a volume of 500mm3 
(TGT500). Lung metastasis were assessed after 2-3 weeks, 
where mice were euthanized, lungs were excised, weighed, 
and stained in Bouin’s solution. Results are listed as Mean (± 
Standard Error). One-way ANOVA comparison of group means 
was performed, and a P<0.05 was considered significant. 
Results: The TGT500 for control animals was 18.3 days (± 0.4) 
for the C3H mammary carcinoma and 13.6 days (± 0.7) for 
the SCCVII carcinoma. Treating the C3H mammary carcinoma 
with KGP94 significantly increased the TGT500 when doses 
were at 5.0 mg/kg or higher. Similar results were found with 
the SCCVII-carcinoma, except that a dose of 5.0 mg/kg did 
not have a significant effect on TGT. At lower doses of KGP94 
neither of the tumour models showed significant growth 
delay. Studies on metastasis formation showed that 50% of 
animals in the control group developed metastasis within 2-3 
weeks. The mean number of metastasis in these mice was 16 
(±15). When mice were treated with KGP94 (10mg/kg) on a 
daily basis only 30% developed metastasis, and the mean 
number of metastasis in these mice was 5 (±4). 
Conclusion: We have shown that inhibiting cathepsin L during 
the tumour initiation stage significantly delays tumour 
growth in the C3H and SCCVII murine tumour models. 
Furthermore, our metastasis study showed decreased 
metastasis formation in KGP94 treated animals. This suggests 
that KGP94 treatment can affect both tumour initiation and 
metastasis formation. 
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Many human tumors contain substantial regions of low oxygen 
(hypoxia), which promotes metastasis and resistance to most 
forms of therapy. Unfortunately, the methods available to 
assess cellular hypoxia are unable to detect the fluctuating 
oxygen concentrations that are proposed to be an important 
source of these cellular phenotypes, and similarly cannot 
detect changes in hypoxia as a consequence of treatment. 
We have established a novel method that enables 
measurement of dynamic changes in hypoxia at the cellular 
level. We developed a series of small molecule probes with 
identical chemical structures but containing different 
isotopes of tellurium that can be independently quantified by 
mass cytometry (MC) and imaging mass cytometry (IMC). This 
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technology allows highly multiparameter (up to 34 probes) 
cytometric or image based quantification of biomarkers on 
single cells. MC employs inductively coupled plasma mass 
spectrometric detection in place of the fluorescence optics 
used in traditional flow and imaging cytometry and 
circumvents the problems of spectral overlap and 
compensation required in fluorescence flow cytometry. The 
key feature of MC that we have exploited is that different 
mass isotopes of the same heavy metal can be independently 
quantified and thus used as distinct probes to allow serial 
measurements over time with the same chemical probe. This 
has allowed a series of probes that have identical 
pharmacokinetic profiles to be produced and used to monitor 
the time dependence of tumor hypoxia in both in vitro and in 
vivo model systems. 
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Purpose: Head and neck squamous cells carcinomas (HNSCC) 
have a poor prognosis due to escapement to anti-cancer 
therapies which leads to locoregional recurrences. The 
presence of cancer stem cells (CSCs), resistant to chemo- and 
radio-therapies, could explain these resistances and 
recurrences. Hadrontherapy has demonstrated favorable 
results for many cancers, since carbon ions induced more 
CSC’s cell death than photons. However, for the HNSCC 
tumor, local control remains low. CSCs are located in a 
hypoxic microenvironment and hypoxia is well-known for 
being able to induce the epithelial mesenchymal transition 
(EMT). The aim of this study is to investigate the response of 
CSCs to radiotherapy, compared with carbon ions under 
hypoxic conditions. Many signaling pathways involved in the 
resistance of CSCs and the invasion/migration process depend 
on the stabilization of HIF-1α. Reactive Oxygen Species 
(ROS), which are produced under hypoxia and in response to 
irradiation, play a key role in this stabilization. However, 
since few data are available, the mechanisms involving ROS 
production, HIF-1α stabilization as well as the 
invasion/migration process that follows, need to be clarified 
in HNSCC CSCs exposed to carbon or photon radiations in a 
hypoxic environment.  
Material and methods: Two HNSCC cells lines, SQ20B and 
FaDu, and their CSCs were grown in normoxic and hypoxic 
(1% O2) conditions. CSCs were isolated by flow cytometry cell 
sorting. Cell survival curves were performed in response to 
photon (250kV) and carbon ion (75MeV/n, GANIL, France) 
irradiations in order to define the Oxygen Enhancement Ratio 
(OER). The expression of HIF-1α was followed by Western-
Blots. ROS were quantified with a CM-H2DCFDA dye and 
Migration/Invasion with Boyden chambers. 
Results: After photons, HNSCC cells and their CSCs appeared 
more resistant under hypoxia (OER>1.2) whereas the oxygen 
effects were cancelled after carbon ions (OER=1). 
Interestingly, the OER values and the expression of HIF-1α 
seemed to be linked. HIF-1α was weakly expressed after 
photon irradiation and fully inhibited after carbon ions. 
Additionally, under hypoxia, HIF-1α expression appeared 
earlier in CSCs than in the parental cell lines, confirming 
their adaptive properties to hypoxia. In CSCs, this expression 
was correlated with ROS levels. As a consequence, since HIF-
1α is known to promote EMT, under normoxia as well as 
hypoxia, the invasion/migration abilities of CSCs were more 
important than in non-CSCs. Finally, after carbon ions, either 
in normoxic or hypoxic conditions, invasion/migration 
processes were decreased compared with photons. 
Conclusion: HIF-1α plays a key role in the radioresistance of 
CSCs and in their invasiveness abilities. No expression of HIF-
1α was found after carbon ion exposure suggesting that 
carbon ions could be a relevant therapeutic alternative to kill 
CSCs in their microenvironment.  
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Purpose: Annular phased array systems (APAS) are suitable to 
heat extremity, pelvic and abdominal tumors and to intensify 
chemo- or radiotherapy (Issels 2010). In a hybrid approach 
APAS and 1.5 T MR scanner were combined and clinically 
validated (Gellermann 2005, 2006). A review is presented 
regarding available technical solutions, its limitations and the 
potentials for further developments.  
Methods: Dedicated high-frequency (filters, matching) and 
mechanical solutions are required for a running hybrid system 
shown in the upper part of the figure. This APA system has an 
operating frequency of 100 MHz while the MR resonance 
frequency is at 64 MHz (1.5 T). Gradient-echo sequences are 
employed to measure phase differences and extracting MR-
temperatures (Gellermann 2005a). The key to obtain reliable 
MR-temperatures is post processing and visualization of MR 
datasets in a suitable software platform (here Hyperplan). 
Software modules has been developed for drift correction 
(via water bolus, calibrating probes, fat tissue), calculation 
and image processing of 3D MR-temperature distributions. 
The platform is also used for hyperthermia treatment 
planning (HTP) in order to compare distributions of pre-
planning and online measurements. Simultaneous processing 
of HTP distributions and registered MR-temperature 
distributions has been implemented in the hybrid system in 
Berlin (Weihrauch 2007). 
Results: The hybrid system was verified in a heterogeneous 
phantom (MR-temperature vs. direct temperature 
measurements, Gellermann 2005a) and clinically used for 
pelvic and extremity tumors under routine conditions 
(Gellermann 2005b, 2006). With available MR sequences 
(phase measurements) MR thermography is suitable for 
extensive fixated tumors such as sarcoma and recurrent 
rectal carcinoma, but not in the abdomen.  
Further developments of temperature sensitive MR sequences 
(Winter 2016) are strongly desirable in order to correct for 
tissue heterogeneities (e.g. air, clips) and various forms of 
motion (pulsation, respiration, peristalsis, different filling in 
case of bladder etc.). MR thermometry of the liver is already 
used during thermoablation, but is a challenge for 
hyperthermia, where errors < 1 °C are requested. 
The next technological step is an integrated system (lower 
part of the figure), where multi-antenna applicators have 
antennas for both heating (i.e. emitting strong phase 
controlled E-fields) and MR imaging (i.e. transmitting 
magnetic pulses and receiving the imaging signals). An 
experimental integrated system (7T, 298 MHz) has been 
implemented and tested (Winter 2013, 2015). Integrated 
systems are also conceivable with lower static H-fields and 
frequencies. 
Conclusion: Current hybrid systems should be further 
developed to integrated multi-channel systems with 
increased signal-to-noise ratio and the capability of online 
optimization. 
 
